Jul 4, 2023EDQM Strasbourg, France 05/06/2023
The European Directorate for the Quality of Medicines & HealthCare (EDQM) has published its 2022...
May 15, 2023EDQM Strasbourg, France 05/05/2023
Messenger RNA (mRNA) vaccines have been at the forefront of vaccine development efforts during...
Feb 27, 2023
Independent control of COVID-19 vaccines: article co-authored by the EDQM and members of the OCABR Network published in npj VaccinesEDQM Strasbourg, France 27/02/2023
The European Directorate for the Quality of Medicines & HealthCare (EDQM) and members* of the...
The EDQM’s contributions to the protection of public health in the COVID-19 pandemic
EDQM business continuity plan to safeguard core activities
The EDQM’s core activities include the provision of documentary and physical (reference) standards to ensure the quality of medicines and their ingredients. Availability of and access for patients to quality medicines is more important than ever in the context of the current COVID-19 pandemic. This is why the EDQM is working hard to ensure the continuous supply of its goods and services and is engaging with all stakeholders, including national, European and international authorities, to support public health protection.
COVID-19 vaccines and therapies: EDQM initiatives
The EDQM is committed to supporting competent authorities and health professionals during the COVID-19 pandemic – as well as contributing to the wider global effort to combat the virus – by openly sharing knowledge and offering free access to relevant standards and guidance.
- WHO: COVID-19 updates
- EMA: COVID-19 page
- ECDC: European Centre for Disease Prevention and Control
The European Centre for Disease Prevention and Control has published advice in a report entitled “Infection prevention and control in the household management of people with suspected or confirmed coronavirus disease (COVID-19)”.
- European Commission: Coronavirus response
- European Commission: Safe COVID-19 vaccines for Europeans